Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

CLINICAL EVALUATION OF METHYLPHENIDATE (RITALIN) HYDROCHLORIDE IN THE NEWBORN INFANT

CLINICAL EVALUATION OF METHYLPHENIDATE (RITALIN) HYDROCHLORIDE IN THE NEWBORN INFANT Methylphenidate (Ritalin) hydrochloride was administered intramuscularly to a group of 54 moderately or heavily medicated obstetric patients. It effectively reduced the depression of their newborn infants. The optimum dose appeared to be 0.1 to 0.2 mg. per pound (0.045 to 0.090 mg. per kilogram) of body weight. Subsequently it was found more practical to administer the drug intramuscularly directly to depressed infants after performing adequate oxygenation. Methylphenidate is not a substitute for oxygenation. Methylphenidate produced a marked increase in respiratory activity within 1 or 2 minutes and increased crying and body activity within 5 to 10 minutes. If the depression recurs, repeated administration of the drug is suggested. The drug produced mild side-effects, consisting in mild rise of the blood pressure and momentary nausea or retching. Methylphenidate may be used to supplement a specific narcotic antagonist, if the depression is attributable to a narcotic or to a combination of a narcotic and other depressants. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

CLINICAL EVALUATION OF METHYLPHENIDATE (RITALIN) HYDROCHLORIDE IN THE NEWBORN INFANT

JAMA , Volume 170 (12) – Jul 18, 1959

Loading next page...
 
/lp/american-medical-association/clinical-evaluation-of-methylphenidate-ritalin-hydrochloride-in-the-yuCTxpxv60
Publisher
American Medical Association
Copyright
Copyright © 1959 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1959.03010120044012
Publisher site
See Article on Publisher Site

Abstract

Methylphenidate (Ritalin) hydrochloride was administered intramuscularly to a group of 54 moderately or heavily medicated obstetric patients. It effectively reduced the depression of their newborn infants. The optimum dose appeared to be 0.1 to 0.2 mg. per pound (0.045 to 0.090 mg. per kilogram) of body weight. Subsequently it was found more practical to administer the drug intramuscularly directly to depressed infants after performing adequate oxygenation. Methylphenidate is not a substitute for oxygenation. Methylphenidate produced a marked increase in respiratory activity within 1 or 2 minutes and increased crying and body activity within 5 to 10 minutes. If the depression recurs, repeated administration of the drug is suggested. The drug produced mild side-effects, consisting in mild rise of the blood pressure and momentary nausea or retching. Methylphenidate may be used to supplement a specific narcotic antagonist, if the depression is attributable to a narcotic or to a combination of a narcotic and other depressants.

Journal

JAMAAmerican Medical Association

Published: Jul 18, 1959

There are no references for this article.